UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000010408
Receipt No. R000012178
Official scientific title of the study Efficacy of donepezil in Alzheimer's disease combined with cerebrovascular disease
Date of disclosure of the study information 2013/04/07
Last modified on 2016/10/05 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Efficacy of donepezil in Alzheimer's disease combined with cerebrovascular disease
Title of the study (Brief title) Donepezil in Alzheimer's disease combined with cerebrovascular disease
Region
Japan

Condition
Condition Alzheimer's disease
Classification by specialty
Medicine in general
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effects of donepezile in patients with a diagnosis of Alzheimer's disease combined with cerebrovascular disease.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes MMSE-J
Key secondary outcomes CDR

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Alzheimer disease
Interventions/Control_2 Alzheimer disease ombined with cerebrovascular disease
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
65 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Alzheimer disease or Alzheimer disease ombined with cerebrovascular disease
Key exclusion criteria other dementia
Target sample size 460

Research contact person
Name of lead principal investigator Norihiro Suzuki
Organization Keio University,
Division name Department of Neurology
Address 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
TEL 0353633788
Email nrsuzuki@a2.keio.jp

Public contact
Name of contact person Daisuke Ito
Organization Keio University,
Division name Department of Neurology
Address 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
TEL 0353633788
Homepage URL
Email d-ito@jk9.so-net.ne.jp

Sponsor
Institute Department of Neurology, Keio University,
Institute
Department

Funding Source
Organization Department of Neurology, Keio University,
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 04 Month 07 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2013 Year 04 Month 06 Day
Anticipated trial start date
2013 Year 05 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results The entry of the study cooperator was difficult within research period.
Other related information

Management information
Registered date
2013 Year 04 Month 03 Day
Last modified on
2016 Year 10 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012178